Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 1/2007

01.01.2007

Resection of Hepatic Colorectal Metastases Involving the Caudate Lobe: Perioperative Outcome and Survival

verfasst von: Eddie K. Abdalla, Dario Ribero, Timothy M. Pawlik, Daria Zorzi, Steven A. Curley, Andrea Muratore, Axel Andres, Gilles Mentha, Lorenzo Capussotti, Jean-Nicolas Vauthey

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Purpose:

To examine clinical features and outcome of patients who underwent hepatic resection for colorectal liver metastases (LM) involving the caudate lobe.

Patients and Methods:

Consecutive patients who underwent hepatic resection for LM from May 1990 to September 2004 were analyzed from a multicenter database. Demographics, operative data, pathologic margin status, recurrence, and survival were analyzed.

Results:

Of 580 patients, 40 (7%) had LM involving the caudate. Six had isolated caudate LM and 34 had LM involving the caudate plus one or more other hepatic segments. Patients with caudate LM were more likely to have synchronous primary colorectal cancer (63% vs. 36%; P = 0.01), multiple LM (70% vs. 51%; P = 0.02) and required extended hepatic resection more often than patients with non-caudate LM (60% vs. 18%; P < 0.001). Only four patients with caudate LM underwent a vascular resection; three at first operation, one after recurrence of a resected caudate tumor. All had primary repair (vena cava, n = 3; portal vein, n = 1). Perioperative complications (43% vs. 28%) and 60-day operative mortality (0% vs. 1%) were similar (caudate vs. non-caudate LM, both P > 0.05). Pathological margins were positive in 15 (38%) patients with caudate LM and in 43 (8%) with non-caudate LM (P < 0.001). At a median follow-up of 40 months, 25 (64%) patients with caudate LM recurred compared with 219 (40%) patients with non-caudate LM (P = 0.01). Patients with caudate LM were more likely to have intrahepatic disease as a component of recurrence (caudate: 51% vs. non-caudate: 25%; P = 0.001). No patient recurred on the vena cava or portal vein. Patients with caudate LM had shorter 5-year disease-free and overall survival than patients with non-caudate LM (disease-free: 24% vs. 44%; P = 0.02; overall: 41% vs. 58%; P = 0.02).

Conclusions:

Patients who undergo hepatic resection for caudate LM often present with multiple hepatic tumors and tumors in proximity to the major hepatic veins. Extended hepatectomy is required in the majority, although vascular resection is not frequently necessary; when performed, primary repair is usually possible. Despite resection in this population of patients with multiple and bilateral tumors, and despite close-margin and positive-margin resection in a significant proportion, recurrence on the portal vein or vena cava was not observed, and long-term survival is accomplished (41% 5-year overall survival).
Literatur
1.
Zurück zum Zitat Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: Expert Consensus Statement. Ann Surg Oncol 2006 13(10), 1271–1280.PubMedCrossRef Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: Expert Consensus Statement. Ann Surg Oncol 2006 13(10), 1271–1280.PubMedCrossRef
2.
Zurück zum Zitat Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759–766.PubMedCrossRef Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759–766.PubMedCrossRef
3.
Zurück zum Zitat Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818–25; discussion 825–827.PubMedCrossRef Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818–25; discussion 825–827.PubMedCrossRef
4.
Zurück zum Zitat Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438–47; discussion 447–450.PubMedCrossRef Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438–47; discussion 447–450.PubMedCrossRef
5.
Zurück zum Zitat Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241:715–722.PubMedCrossRef Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241:715–722.PubMedCrossRef
6.
Zurück zum Zitat Aloia TA, Vauthey JN, Loyer EM, Ribero D, Ahrar K, Pawlik TM, Zorzi D, Abdalla EK. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 2006;141:460–467.PubMedCrossRef Aloia TA, Vauthey JN, Loyer EM, Ribero D, Ahrar K, Pawlik TM, Zorzi D, Abdalla EK. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 2006;141:460–467.PubMedCrossRef
7.
Zurück zum Zitat Kumon M. Anatomy of the caudate lobe with special reference to portal vein and bile duct. Acta Hepatol Jpn 1985;26:1193–1199. Kumon M. Anatomy of the caudate lobe with special reference to portal vein and bile duct. Acta Hepatol Jpn 1985;26:1193–1199.
8.
Zurück zum Zitat Kogure K, Kuwano H, Fujimaki N, Makuuchi M. Relation among portal segmentation, proper hepatic vein, and external notch of the caudate lobe in the human liver. Ann Surg 2000;231:223–228.PubMedCrossRef Kogure K, Kuwano H, Fujimaki N, Makuuchi M. Relation among portal segmentation, proper hepatic vein, and external notch of the caudate lobe in the human liver. Ann Surg 2000;231:223–228.PubMedCrossRef
9.
Zurück zum Zitat Abdalla EK, Vauthey JN, Couinaud C. The caudate lobe of the liver: implications of embryology and anatomy for surgery. Surg Oncol Clin N Am 2002;11:835–848.PubMedCrossRef Abdalla EK, Vauthey JN, Couinaud C. The caudate lobe of the liver: implications of embryology and anatomy for surgery. Surg Oncol Clin N Am 2002;11:835–848.PubMedCrossRef
10.
Zurück zum Zitat Yanaga K, Matsumata T, Hayashi H, Shimada M, Urata K, Sugimachi K. Isolated hepatic caudate lobectomy. Surgery 1994;115:757–761.PubMed Yanaga K, Matsumata T, Hayashi H, Shimada M, Urata K, Sugimachi K. Isolated hepatic caudate lobectomy. Surgery 1994;115:757–761.PubMed
11.
Zurück zum Zitat Bartlett D, Fong Y, Blumgart LH. Complete resection of the caudate lobe of the liver: technique and results. Br J Surg 1996;83:1076–1081.PubMed Bartlett D, Fong Y, Blumgart LH. Complete resection of the caudate lobe of the liver: technique and results. Br J Surg 1996;83:1076–1081.PubMed
12.
Zurück zum Zitat Sasada A, Ataka K, Tsuchiya K, Yamagishi H, Maeda H, Okada M. Complete caudate lobectomy: its definition, indications, and surgical approaches. HPB Surg 1998;11:87–93.PubMed Sasada A, Ataka K, Tsuchiya K, Yamagishi H, Maeda H, Okada M. Complete caudate lobectomy: its definition, indications, and surgical approaches. HPB Surg 1998;11:87–93.PubMed
13.
Zurück zum Zitat Fan J, Wu ZQ, Tang ZY, Zhou J, Qiu SJ, Ma ZC, Zhou XD, Yu YQ. Complete resection of the caudate lobe of the liver with tumor: technique and experience. Hepato-Gastroenterology 2001;48:808–811.PubMed Fan J, Wu ZQ, Tang ZY, Zhou J, Qiu SJ, Ma ZC, Zhou XD, Yu YQ. Complete resection of the caudate lobe of the liver with tumor: technique and experience. Hepato-Gastroenterology 2001;48:808–811.PubMed
14.
Zurück zum Zitat Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002;137:675-680; discussion 680–681.PubMedCrossRef Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002;137:675-680; discussion 680–681.PubMedCrossRef
15.
Zurück zum Zitat Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, Hicks M, Alsfasser G, Lauwers G, Hawkins IF, Caridi J. Standardized measurement of the future liver remnant prior to extended liver resection: Methodology and clinical associations. Surgery 2000;127:512–519.PubMedCrossRef Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, Hicks M, Alsfasser G, Lauwers G, Hawkins IF, Caridi J. Standardized measurement of the future liver remnant prior to extended liver resection: Methodology and clinical associations. Surgery 2000;127:512–519.PubMedCrossRef
16.
Zurück zum Zitat Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 2005;12:351–355.PubMedCrossRef Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 2005;12:351–355.PubMedCrossRef
17.
Zurück zum Zitat Strasberg SM. International Hepato-Pancreato-Biliary Association Terminology Committee Survey: the Brisbane 2000 Terminology of Liver Anatomy and Resections. HPB 2000;2:333–339. Strasberg SM. International Hepato-Pancreato-Biliary Association Terminology Committee Survey: the Brisbane 2000 Terminology of Liver Anatomy and Resections. HPB 2000;2:333–339.
18.
Zurück zum Zitat Elias D, Lasser PH, Desruennes E, Mankarios H, Detroz B. Surgical approaches to segment I for malignant tumors (20 cases). J Chir (Paris) 1993;130:335–342. Elias D, Lasser PH, Desruennes E, Mankarios H, Detroz B. Surgical approaches to segment I for malignant tumors (20 cases). J Chir (Paris) 1993;130:335–342.
19.
Zurück zum Zitat Morise Z, Yamafuji K, Asami A, Takeshima K, Hayashi N, Baba H, Endo T, Hattori T, Ito Y, Tokura Y. Hepatectomy following transarterial chemotherapy for a metastasis in the caudate lobe. Hepato-Gastroenterology 2004;51:583–585.PubMed Morise Z, Yamafuji K, Asami A, Takeshima K, Hayashi N, Baba H, Endo T, Hattori T, Ito Y, Tokura Y. Hepatectomy following transarterial chemotherapy for a metastasis in the caudate lobe. Hepato-Gastroenterology 2004;51:583–585.PubMed
20.
Zurück zum Zitat Yamamoto H, Nagino M, Kamiya J, Hayakawa N, Nimura Y. Surgical treatment for colorectal liver metastases involving the paracaval portion of the caudate lobe. Surgery 2005;137:26–32.PubMedCrossRef Yamamoto H, Nagino M, Kamiya J, Hayakawa N, Nimura Y. Surgical treatment for colorectal liver metastases involving the paracaval portion of the caudate lobe. Surgery 2005;137:26–32.PubMedCrossRef
21.
Zurück zum Zitat Hawkins WG, DeMatteo RP, Cohen MS, Jarnagin WR, Fong Y, D'Angelica M, Gonen M, Blumgart LH. Caudate hepatectomy for cancer: a single institution experience with 150 patients. J Am Coll Surg 2005;200:345–352.PubMedCrossRef Hawkins WG, DeMatteo RP, Cohen MS, Jarnagin WR, Fong Y, D'Angelica M, Gonen M, Blumgart LH. Caudate hepatectomy for cancer: a single institution experience with 150 patients. J Am Coll Surg 2005;200:345–352.PubMedCrossRef
22.
Zurück zum Zitat Tanaka K, Shimada H, Matsuo K, Nagano Y, Togo S. Surgical outcome of solitary colorectal metastasis to the hepatic caudate lobe. Br J Surg. 2005;92:847–848.PubMedCrossRef Tanaka K, Shimada H, Matsuo K, Nagano Y, Togo S. Surgical outcome of solitary colorectal metastasis to the hepatic caudate lobe. Br J Surg. 2005;92:847–848.PubMedCrossRef
23.
Zurück zum Zitat Kosuge T, Yamamoto J, Takayama T, Shimada K, Yamasaki S, Makuuchi M, Hasegawa H. An isolated, complete resection of the caudate lobe, including the paracaval portion, for hepatocellular carcinoma. Arch Surg 1994;129:280–284.PubMed Kosuge T, Yamamoto J, Takayama T, Shimada K, Yamasaki S, Makuuchi M, Hasegawa H. An isolated, complete resection of the caudate lobe, including the paracaval portion, for hepatocellular carcinoma. Arch Surg 1994;129:280–284.PubMed
24.
Zurück zum Zitat Asahara T, Dohi K, Hino H, Nakahara H, Katayama K, Itamoto T, E. O, Moriwaki K, Yuge O, Nakanishi T, Kitamoto M. Isolated caudate lobectomy by anterior approach for hepatocellular carcinoma originating in the paracaval portion of the caudate lobe. J Hepatobiliary Pancreat Surg 1998;5:416–421.PubMedCrossRef Asahara T, Dohi K, Hino H, Nakahara H, Katayama K, Itamoto T, E. O, Moriwaki K, Yuge O, Nakanishi T, Kitamoto M. Isolated caudate lobectomy by anterior approach for hepatocellular carcinoma originating in the paracaval portion of the caudate lobe. J Hepatobiliary Pancreat Surg 1998;5:416–421.PubMedCrossRef
25.
Zurück zum Zitat Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T, Makuuchi M. Anterior transhepatic approach for isolated resection of the caudate lobe of the liver. World J Surg 1999;23:97–101.PubMedCrossRef Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T, Makuuchi M. Anterior transhepatic approach for isolated resection of the caudate lobe of the liver. World J Surg 1999;23:97–101.PubMedCrossRef
26.
Zurück zum Zitat Sarmiento JM, Que FG, Nagorney DM. Surgical outcomes of isolated caudate lobe resection: a single series of 19 patients. Surgery 2002;132:697–708; discussion 708–709.PubMedCrossRef Sarmiento JM, Que FG, Nagorney DM. Surgical outcomes of isolated caudate lobe resection: a single series of 19 patients. Surgery 2002;132:697–708; discussion 708–709.PubMedCrossRef
27.
Zurück zum Zitat Vauthey JN, Pawlik TM, Ribero D, Wu T, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK. Chemotherapy regimen predicts steatohepatitis and an increase in 90-Day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065–2072.PubMedCrossRef Vauthey JN, Pawlik TM, Ribero D, Wu T, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK. Chemotherapy regimen predicts steatohepatitis and an increase in 90-Day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065–2072.PubMedCrossRef
28.
Zurück zum Zitat Vauthey JN, Pawlik TM, Abdalla EK, Arens JF, Nemr RA, Wei SH, Kennamer DL, Ellis LM, Curley SA. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 2004;239:722–730; discussion 730–732.PubMedCrossRef Vauthey JN, Pawlik TM, Abdalla EK, Arens JF, Nemr RA, Wei SH, Kennamer DL, Ellis LM, Curley SA. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 2004;239:722–730; discussion 730–732.PubMedCrossRef
29.
Zurück zum Zitat Okada Y, Nagino M, Kamiya J, Yamamoto H, Hayakawa N, Nimura Y. Diagnosis and treatment of inferior vena caval invasion by hepatic cancer. World J Surg 2003;27:689–694.PubMedCrossRef Okada Y, Nagino M, Kamiya J, Yamamoto H, Hayakawa N, Nimura Y. Diagnosis and treatment of inferior vena caval invasion by hepatic cancer. World J Surg 2003;27:689–694.PubMedCrossRef
30.
Zurück zum Zitat Nardo B, Ercolani G, Montalti R, Bertelli R, Gardini A, Beltempo P, Puviani L, Pacile V, Vivarelli M, Cavallari A. Hepatic resection for primary or secondary malignancies with involvement of the inferior vena cava: is this operation safe or hazardous? J Am Coll Surg 2005;201:671–679.PubMedCrossRef Nardo B, Ercolani G, Montalti R, Bertelli R, Gardini A, Beltempo P, Puviani L, Pacile V, Vivarelli M, Cavallari A. Hepatic resection for primary or secondary malignancies with involvement of the inferior vena cava: is this operation safe or hazardous? J Am Coll Surg 2005;201:671–679.PubMedCrossRef
31.
Zurück zum Zitat Venook A. Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist 2005;10:250–261.PubMedCrossRef Venook A. Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist 2005;10:250–261.PubMedCrossRef
Metadaten
Titel
Resection of Hepatic Colorectal Metastases Involving the Caudate Lobe: Perioperative Outcome and Survival
verfasst von
Eddie K. Abdalla
Dario Ribero
Timothy M. Pawlik
Daria Zorzi
Steven A. Curley
Andrea Muratore
Axel Andres
Gilles Mentha
Lorenzo Capussotti
Jean-Nicolas Vauthey
Publikationsdatum
01.01.2007
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 1/2007
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-006-0045-3

Weitere Artikel der Ausgabe 1/2007

Journal of Gastrointestinal Surgery 1/2007 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.